Market Overview

UPDATE: Morgan Stanley Initiates Coverage on Envision Healthcare on Reform Pure Play

Share:
Related EVHC
Analyst: Buy CRH Medical After An 'Overdone' Selloff
Why You Should Avoid Envision Healthcare (EVHC) Stock Now

In a report published Monday, Morgan Stanley analyst Andrew Schenker initiated coverage on Envision Healthcare Holdings (NYSE: EVHC) with an Overweight rating and $33.00 price target.

In the report, Morgan Stanley noted, “We are initiating coverage of EVHC at Overweight with a $33 price target. EVHC is one of the purest plays on healthcare reform, benefiting from the decline in the uninsured for its emergency department (EmCare) and ambulance (AMR) services without the related reimbursement risk.”

Envision Healthcare Holdings closed on Friday at $26.84.

Latest Ratings for EVHC

DateFirmActionFromTo
Dec 2016BarclaysReinstatesOverweight
Dec 2016OppenheimerUpgradesPerformOutperform
Dec 2016JefferiesMaintainsBuy

View More Analyst Ratings for EVHC
View the Latest Analyst Ratings

Posted-In: Andrew Schenker Morgan StanleyAnalyst Color Initiation Analyst Ratings

 

Related Articles (EVHC)

View Comments and Join the Discussion!